Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Consensus Recommendation of “Hold” by Brokerages

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has received a consensus recommendation of “Hold” from the four analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $4.00.

A number of equities research analysts recently issued reports on the company. Wall Street Zen cut Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research note on Saturday, April 4th. Weiss Ratings upgraded shares of Bioceres Crop Solutions from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, June 26th.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of large investors have recently made changes to their positions in the stock. Marshall Wace LLP raised its stake in shares of Bioceres Crop Solutions by 180.0% during the 4th quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock valued at $780,000 after purchasing an additional 382,744 shares during the period. GAM Holding AG purchased a new position in Bioceres Crop Solutions during the 4th quarter valued at about $655,000. Ardsley Advisory Partners LP grew its holdings in Bioceres Crop Solutions by 691.7% during the 4th quarter. Ardsley Advisory Partners LP now owns 475,000 shares of the company’s stock valued at $622,000 after buying an additional 415,000 shares in the last quarter. Susquehanna International Group LLP bought a new stake in shares of Bioceres Crop Solutions during the third quarter valued at about $315,000. Finally, Tudor Investment Corp ET AL lifted its holdings in shares of Bioceres Crop Solutions by 119.4% in the third quarter. Tudor Investment Corp ET AL now owns 220,500 shares of the company’s stock worth $311,000 after buying an additional 120,000 shares in the last quarter. 17.68% of the stock is owned by institutional investors.

Bioceres Crop Solutions Price Performance

Shares of NASDAQ BIOX remained flat at $0.33 during mid-day trading on Friday. The stock had a trading volume of 111,171 shares, compared to its average volume of 231,477. The firm has a market cap of $20.93 million, a price-to-earnings ratio of -0.09 and a beta of 0.42. Bioceres Crop Solutions has a 12 month low of $0.31 and a 12 month high of $5.00. The company has a quick ratio of 0.70, a current ratio of 0.88 and a debt-to-equity ratio of 0.57. The stock has a 50 day moving average price of $0.43 and a 200-day moving average price of $0.69.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings results on Monday, May 11th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.11). The company had revenue of $39.40 million for the quarter, compared to the consensus estimate of $54.50 million. Bioceres Crop Solutions had a negative net margin of 92.85% and a negative return on equity of 33.97%. As a group, sell-side analysts forecast that Bioceres Crop Solutions will post -0.16 EPS for the current fiscal year.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.